Added benefit of aclidinium bromide is not proven

(Institute for Quality and Efficiency in Health Care) In an early benefit assessment IQWiG examined whether aclidinium bromide alleviates symptoms of chronic-obstructive pulmonary disease better than conventional drugs. However, such an added benefit cannot be inferred from the drug manufacturer's dossier as it does not provide robust results.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news